Concepedia

M.C. Cox

MC

Statistics

Publications

10

Citations

534

H-Index

10

Active since

2011

Affiliations

Loxo Oncology at Lilly (United States)(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

Cornell University

M.C. Cox is an author at Loxo Oncology at Lilly (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

2011–2024

10

Publications

10

A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome

Emma Benton, Siobhan Crichton, R. Talpur et al. · European Journal of Cancer · 2013 · 158 citations

Medicine, Dermatology, Oncology +13

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

David S. Hong, Todd M. Bauer, Afshin Dowlati et al. · Annals of Oncology · 2019 · 153 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

Fiona L. Dignan, Danielle Greenblatt, M.C. Cox et al. · Bone Marrow Transplantation · 2011 · 66 citations

Medicine, Dermatology, Surgery +4

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Ulrik Lassen, Catherine M. Albert, Shivaani Kummar et al. · Annals of Oncology · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion

Stefan Bielack, M.C. Cox, Michaela Nathrath et al. · Annals of Oncology · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 10